Indeed, although the identity of the palmitoylated proteins in EV was not identified and it is still unknown how palmitoylation triggers TLR2 activation, AML cells treated with 2-BP lost the capacity to generate MDSC and an immune-suppressive environment for their survival. Here, TLR2 is linked to acute myeloid leukemia.